نتایج جستجو برای: antipsychotic agents

تعداد نتایج: 364374  

Journal: :Psychoneuroendocrinology 2003
U Halbreich B J Kinon J A Gilmore L S Kahn

The neurologic processes involved in schizophrenia are complex and diverse and the mechanisms through which antipsychotic agents exert their effects have been only partly elucidated. Hyperprolactinemia is a common side effect of treatment with many antipsychotics and is particularly associated with conventional ('typical') agents as well as the atypical antipsychotic risperidone. In contrast, o...

Journal: :Pharmacoepidemiology and drug safety 2011
G C Alexander S A Gallagher A Mascola R M Moloney R S Stafford

OBJECTIVE To evaluate patterns of antipsychotic use. DESIGN, SETTING, AND MEASUREMENTS: We used nationally representative data from the IMS Health National Disease and Therapeutic Index to describe outpatient antipsychotic use. The primary outcome was the volume of visits where antipsychotics were used for specific indications (treatment visits). We also quantified use without U.S. Food and Dru...

Journal: :The Journal of clinical psychiatry 2001
S M Stahl

Either 5-HT2A antagonism or fast dissociation from D2 receptors may define an atypical antipsychotic. To have little or no motor symptoms from an antipsychotic, it is clear that D2 receptor binding in the striatum must be less than that caused by conventional antipsychotics. Pure 5-HT2A antagonism by itself does not result in robust antipsychotic actions. However, 5-HT2A antagonism can reduce D...

Journal: :P & T : a peer-reviewed journal for formulary management 2011
Jonathan R Scarff David A Casey

“black-box” warnings for all antipsychotic drugs.2 Antipsychotic agents may be classified in several ways. Commonly, they can be designated as older drugs (often called conventional or “typical” antipsychotics) and newer “atypicals.” The term atypical refers to the perceived lower likelihood of extrapyramidal symptoms, a sequela that had been deemed characteristic of the first generation of ant...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 1974
M Karobath H Leitich

Antipsychotic drugs and their clinically impotent congeners were examined as inhibitors of dopamine-sensitive adenylate cyclase (EC 4.6.1.1) in cell-free membrane preparations of the caudate-putamen of rat brain. Of 12 neuroleptic drugs with reported antipsychotic efficacy, all inhibit stimulation of adenylate cyclase by 40 muM dopamine at micromolar concentrations. Among 14 other structurally ...

Journal: :Annals of General Psychiatry 2005
Michela Sala Alessandro Vicentini Paolo Brambilla Cristina Montomoli Jigar RS Jogia Eduardo Caverzasi Alberto Bonzano Marco Piccinelli Francesco Barale Gaetano M De Ferrari

BACKGROUND: Several antipsychotic agents are known to prolong the QT interval in a dose dependent manner. Corrected QT interval (QTc) exceeding a threshold value of 450 ms may be associated with an increased risk of life threatening arrhythmias. Antipsychotic agents are often given in combination with other psychotropic drugs, such as antidepressants, that may also contribute to QT prolongation...

2004
Kimberly H. Littrell

The pharmacologic management of schizophrenia has dramatically improved over the past 50 years. While the first-generation, or conventional, antipsychotic medications were found to be helpful in reducing the positive symptoms of the disorder, they had little effect on negative and cognitive symptoms. Additionally, the first-generation agents were associated with the troubling neurologic side ef...

Journal: :Drug discovery today 2006
Kurt Rasmussen

Antidepressant medications have eased the suffering of millions of people. In addition to treating depression, antidepressant drugs also treat several anxiety disorders. Unfortunately, there are problematic limitations with antidepressant agents, including a delayed therapeutic response and insufficient efficacy. Emerging evidence shows that atypical antipsychotic agents can be used as augmenta...

Journal: :Archives of general psychiatry 2002
Carol E Koro Donald O Fedder Gilbert J L'Italien Sheila Weiss Laurence S Magder Julie Kreyenbuhl Dennis Revicki Robert W Buchanan

BACKGROUND The newer antipsychotic agents exhibit a superior safety profile compared with conventional antipsychotic agents in terms of extrapyramidal symptoms. Previous studies have suggested an association between olanzapine treatment and hyperlipidemia. We evaluated this association using a large health care database. METHODS The study was derived from the England and Wales-based General P...

2009
Xinhua S Ren Lawrence Herz Shirley Qian Eric Smith Lewis E Kazis

The importance of medication adherence in sustaining control of schizophrenic symptoms has generated a great deal of interest in comparing levels of treatment adherence with different antipsychotic agents. However, the bulk of the research has yielded results that are often inconsistent. In this prospective, observational study, we assessed the measurement properties of 3 commonly used, pharmac...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید